Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products.
Cloudy, breezy and cool Friday ahead of a wet weekend in Houston!Read full article: Murder suspect in custody after SWAT standoff at Baytown hotelMajor gas leak reported in N. Harris County, authorities urge people to avoid areaNow is the perfect time to take advantage of our latest Insider Deals that elevate your home, enhance self-care and get you into the holiday spirit.
Lilly said Thursday it will expand a Kenosha County, Wisconsin, factory it bought early this year, and the investment will help meet growing demand for injectable products like its diabetes and obesity drugs, Mounjaro andLilly also announced other multibillion-dollar manufacturing expansion projects near its Indianapolis headquarters earlier this year.
Eli Lilly and Co. said Thursday that it has slated more than $23 billion to construct, expand or acquire manufacturing sites worldwide since 2020. Copyright 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.Now is the perfect time to take advantage of our latest Insider Deals that elevate your home, enhance self-care and get you into the holiday spirit.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, ZepboundEli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products.
Read more »
Drugmaker Lilly to spend another $3B to bulk up manufacturing in WisconsinEli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products. Lilly said Thursday it will expand a Kenosha County, Wisconsin, factory it bought early this year.
Read more »
Stocks making the biggest moves midday: JetBlue, Eli Lilly, Pure Storage, Salesforce and moreThese are the stocks posting the largest moves in midday trading.
Read more »
Eli Lilly: Breakthrough Trial Results Set Stage for Market Growth, Stock GainsStocks Analysis by Michael Lebowitz covering: Eli Lilly and Company, Novo Nordisk A/S. Read Michael Lebowitz's latest article on Investing.com
Read more »
Eli Lilly shares jump on two big updates and Jim Cramer is so here for itThe Biden administration proposed a rule change that would expand access to Eli Lilly's Zepbound. And an obesity drug competitor released disappointing results.
Read more »
Zepbound results in more weight loss than Wegovy in trial, Eli Lilly saysBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »